Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 139 Pages
Report ld: 6554726
Request Sample
Customized Report
The global Reagent Grade Firocoxib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Reagent Grade Firocoxib competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
The North American market for Reagent Grade Firocoxib is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Reagent Grade Firocoxib is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Reagent Grade Firocoxib include BOC Sciences, TargetMol, Merck KgaA, Santa Cruz Biotechnology, Toronto Research Chemicals, Ambinter, Carbosynth, Henan Tianfu Chemical, J&K Scientific, Chemsky International, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Reagent Grade Firocoxib market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Reagent Grade Firocoxib. The Reagent Grade Firocoxib market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Reagent Grade Firocoxib market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Reagent Grade Firocoxib manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Reagent Grade Firocoxib manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Reagent Grade Firocoxib production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Reagent Grade Firocoxib consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Reagent Grade Firocoxib Market Overview
1.1 Product Definition
1.2 Reagent Grade Firocoxib by Type
1.2.1 Global Reagent Grade Firocoxib Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Primary Reagent
1.2.3 Spectrum-Pure Reagent
1.2.4 High-Purity Reagent
1.3 Reagent Grade Firocoxib by Application
1.3.1 Global Reagent Grade Firocoxib Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Veterinary
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Reagent Grade Firocoxib Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Reagent Grade Firocoxib Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Reagent Grade Firocoxib Production Estimates and Forecasts (2021–2032)
1.4.4 Global Reagent Grade Firocoxib Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Reagent Grade Firocoxib Production Market Share by Manufacturers (2021–2026)
2.2 Global Reagent Grade Firocoxib Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Reagent Grade Firocoxib, Industry Ranking, 2024 vs 2025
2.4 Global Reagent Grade Firocoxib Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Reagent Grade Firocoxib Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Reagent Grade Firocoxib, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Reagent Grade Firocoxib, Product Offerings and Applications
2.8 Global Key Manufacturers of Reagent Grade Firocoxib, Date of Entry into the Industry
2.9 Reagent Grade Firocoxib Market Competitive Situation and Trends
2.9.1 Reagent Grade Firocoxib Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Reagent Grade Firocoxib Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Reagent Grade Firocoxib Production by Region
3.1 Global Reagent Grade Firocoxib Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Reagent Grade Firocoxib Production Value by Region (2021–2032)
3.2.1 Global Reagent Grade Firocoxib Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Reagent Grade Firocoxib by Region (2027–2032)
3.3 Global Reagent Grade Firocoxib Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Reagent Grade Firocoxib Production Volume by Region (2021–2032)
3.4.1 Global Reagent Grade Firocoxib Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Reagent Grade Firocoxib by Region (2027–2032)
3.5 Global Reagent Grade Firocoxib Market Price Analysis by Region (2021–2032)
3.6 Global Reagent Grade Firocoxib Production, Value, and Year-over-Year Growth
3.6.1 North America Reagent Grade Firocoxib Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Reagent Grade Firocoxib Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Reagent Grade Firocoxib Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Reagent Grade Firocoxib Production Value Estimates and Forecasts (2021–2032)
4 Reagent Grade Firocoxib Consumption by Region
4.1 Global Reagent Grade Firocoxib Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Reagent Grade Firocoxib Consumption by Region (2021–2032)
4.2.1 Global Reagent Grade Firocoxib Consumption by Region (2021–2026)
4.2.2 Global Reagent Grade Firocoxib Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Reagent Grade Firocoxib Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Reagent Grade Firocoxib Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Reagent Grade Firocoxib Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Reagent Grade Firocoxib Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Reagent Grade Firocoxib Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Reagent Grade Firocoxib Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Reagent Grade Firocoxib Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Reagent Grade Firocoxib Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Reagent Grade Firocoxib Production by Type (2021–2032)
5.1.1 Global Reagent Grade Firocoxib Production by Type (2021–2026)
5.1.2 Global Reagent Grade Firocoxib Production by Type (2027–2032)
5.1.3 Global Reagent Grade Firocoxib Production Market Share by Type (2021–2032)
5.2 Global Reagent Grade Firocoxib Production Value by Type (2021–2032)
5.2.1 Global Reagent Grade Firocoxib Production Value by Type (2021–2026)
5.2.2 Global Reagent Grade Firocoxib Production Value by Type (2027–2032)
5.2.3 Global Reagent Grade Firocoxib Production Value Market Share by Type (2021–2032)
5.3 Global Reagent Grade Firocoxib Price by Type (2021–2032)
6 Segment by Application
6.1 Global Reagent Grade Firocoxib Production by Application (2021–2032)
6.1.1 Global Reagent Grade Firocoxib Production by Application (2021–2026)
6.1.2 Global Reagent Grade Firocoxib Production by Application (2027–2032)
6.1.3 Global Reagent Grade Firocoxib Production Market Share by Application (2021–2032)
6.2 Global Reagent Grade Firocoxib Production Value by Application (2021–2032)
6.2.1 Global Reagent Grade Firocoxib Production Value by Application (2021–2026)
6.2.2 Global Reagent Grade Firocoxib Production Value by Application (2027–2032)
6.2.3 Global Reagent Grade Firocoxib Production Value Market Share by Application (2021–2032)
6.3 Global Reagent Grade Firocoxib Price by Application (2021–2032)
7 Key Companies Profiled
7.1 BOC Sciences
7.1.1 BOC Sciences Reagent Grade Firocoxib Company Information
7.1.2 BOC Sciences Reagent Grade Firocoxib Product Portfolio
7.1.3 BOC Sciences Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 BOC Sciences Main Business and Markets Served
7.1.5 BOC Sciences Recent Developments/Updates
7.2 TargetMol
7.2.1 TargetMol Reagent Grade Firocoxib Company Information
7.2.2 TargetMol Reagent Grade Firocoxib Product Portfolio
7.2.3 TargetMol Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 TargetMol Main Business and Markets Served
7.2.5 TargetMol Recent Developments/Updates
7.3 Merck KgaA
7.3.1 Merck KgaA Reagent Grade Firocoxib Company Information
7.3.2 Merck KgaA Reagent Grade Firocoxib Product Portfolio
7.3.3 Merck KgaA Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Merck KgaA Main Business and Markets Served
7.3.5 Merck KgaA Recent Developments/Updates
7.4 Santa Cruz Biotechnology
7.4.1 Santa Cruz Biotechnology Reagent Grade Firocoxib Company Information
7.4.2 Santa Cruz Biotechnology Reagent Grade Firocoxib Product Portfolio
7.4.3 Santa Cruz Biotechnology Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Santa Cruz Biotechnology Main Business and Markets Served
7.4.5 Santa Cruz Biotechnology Recent Developments/Updates
7.5 Toronto Research Chemicals
7.5.1 Toronto Research Chemicals Reagent Grade Firocoxib Company Information
7.5.2 Toronto Research Chemicals Reagent Grade Firocoxib Product Portfolio
7.5.3 Toronto Research Chemicals Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Toronto Research Chemicals Main Business and Markets Served
7.5.5 Toronto Research Chemicals Recent Developments/Updates
7.6 Ambinter
7.6.1 Ambinter Reagent Grade Firocoxib Company Information
7.6.2 Ambinter Reagent Grade Firocoxib Product Portfolio
7.6.3 Ambinter Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Ambinter Main Business and Markets Served
7.6.5 Ambinter Recent Developments/Updates
7.7 Carbosynth
7.7.1 Carbosynth Reagent Grade Firocoxib Company Information
7.7.2 Carbosynth Reagent Grade Firocoxib Product Portfolio
7.7.3 Carbosynth Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Carbosynth Main Business and Markets Served
7.7.5 Carbosynth Recent Developments/Updates
7.8 Henan Tianfu Chemical
7.8.1 Henan Tianfu Chemical Reagent Grade Firocoxib Company Information
7.8.2 Henan Tianfu Chemical Reagent Grade Firocoxib Product Portfolio
7.8.3 Henan Tianfu Chemical Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Henan Tianfu Chemical Main Business and Markets Served
7.8.5 Henan Tianfu Chemical Recent Developments/Updates
7.9 J&K Scientific
7.9.1 J&K Scientific Reagent Grade Firocoxib Company Information
7.9.2 J&K Scientific Reagent Grade Firocoxib Product Portfolio
7.9.3 J&K Scientific Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 J&K Scientific Main Business and Markets Served
7.9.5 J&K Scientific Recent Developments/Updates
7.10 Chemsky International
7.10.1 Chemsky International Reagent Grade Firocoxib Company Information
7.10.2 Chemsky International Reagent Grade Firocoxib Product Portfolio
7.10.3 Chemsky International Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Chemsky International Main Business and Markets Served
7.10.5 Chemsky International Recent Developments/Updates
7.11 Chemwill Asia
7.11.1 Chemwill Asia Reagent Grade Firocoxib Company Information
7.11.2 Chemwill Asia Reagent Grade Firocoxib Product Portfolio
7.11.3 Chemwill Asia Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Chemwill Asia Main Business and Markets Served
7.11.5 Chemwill Asia Recent Developments/Updates
7.12 ChemeGen
7.12.1 ChemeGen Reagent Grade Firocoxib Company Information
7.12.2 ChemeGen Reagent Grade Firocoxib Product Portfolio
7.12.3 ChemeGen Reagent Grade Firocoxib Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 ChemeGen Main Business and Markets Served
7.12.5 ChemeGen Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Reagent Grade Firocoxib Industry Chain Analysis
8.2 Reagent Grade Firocoxib Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Reagent Grade Firocoxib Production Modes and Processes
8.4 Reagent Grade Firocoxib Sales and Marketing
8.4.1 Reagent Grade Firocoxib Sales Channels
8.4.2 Reagent Grade Firocoxib Distributors
8.5 Reagent Grade Firocoxib Customer Analysis
9 Reagent Grade Firocoxib Market Dynamics
9.1 Reagent Grade Firocoxib Industry Trends
9.2 Reagent Grade Firocoxib Market Drivers
9.3 Reagent Grade Firocoxib Market Challenges
9.4 Reagent Grade Firocoxib Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
The global Reagent Grade Firocoxib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 159
USD 4900.00
(Single User License)
The global market for Reagent Grade Firocoxib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 104
USD 2900.00
(Single User License)
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 113
USD 3950.00
(Single User License)
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published Date: 2024-04-15
Pages: 107
USD 4900.00
(Single User License)
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published Date: 2024-02-23
Pages: 127
USD 3950.00
(Single User License)
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published Date: 2024-01-09
Pages: 100
USD 2900.00
(Single User License)
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 140
The global Reagent Grade Firocoxib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 159
The global market for Reagent Grade Firocoxib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 104
The global market for Reagent Grade Firocoxib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 113
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published: 2024-04-15
Pages: 107
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published: 2024-02-23
Pages: 127
Firocoxib is a nonsteroidal anti-inflammatory medication used to treat pain and inflammation in dogs and horses. It is most frequently used to treat arthritis and pain after surgery or trauma.
Published: 2024-01-09
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now